The near future will witness an increased understanding of the immune system and genomics in cancer. High throughput sequencing technology will expand in parallel with an ever-expanding array of novel therapies. Improved computational power coupled with bioinformatics algorithms will combine the fields of genomics and immunology. The emerging fields that stand to benefit from rapid translation of NGS technology include cancer vaccines and adoptive cell therapy, which will further refine precision oncology.